Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
暂无分享,去创建一个
S. Rapposelli | A. Perra | A. Columbano | C. Manera | A. Caddeo | M. Kowalik | M. Serra | Francesca Sedda | A. Bacci